The lively pulse of Primary Care (with a PA spin) in an entertaining, monthly podcast.

The young febrile infant is at risk for serious infections. Older risk stratification strategies have involved extensive, invasive work-ups. New research from the PECARN group has allowed for a simpler evaluation of the full term, well appearing febrile young infant using only blood and urine testing. Sol sits down with fellow EM physician, and founding chair of the PECARN network, Dr. Nate Kuppermann to discuss the latest trends in evaluating this high risk population.

In this Hippo Education bonus, Dr. Rob Orman digs into the data just published regarding mRNA vaccine safety in pregnant patients, and what it means for our patients. He also reviews data just published looking at the effect of COVID on maternal and neonatal morbidity and mortality among pregnant women.

Covid isn’t going anywhere. And neither is Long Covid, or as it’s now called, Post-Acute Sequelae of SARS-CoV-2, or PASC. We sit down with pulmonologist, critical care physician, and emerging PASC expert Dr. Andi Levine from the University of Maryland School of Medicine to learn all about this challenging syndrome and how front-line clinicians can best approach its workup and treatment.

The news this week has been replete with stories about increased clot risk in those who have received the AstraZeneca and Johnson & Johnson COVID-19 vaccines. In this episode, we break down: what we know so far about vaccine induced thrombotic thrombocytopenia (VITT), the research that has revealed an underlying mechanism, CDC and NHS recommendations, and a primer on cerebral venous thrombosis -- the primary clot site associated with VITT.